1 |
Adkins, J.N., Varnum, S.M., Auberry, K.J., Moore, R.J., Angell, N.H., Smith, R.D., Springer, D.L., and Pounds, J.G. (2002). Toward a human blood serum proteome. Analysis by multidimensional separation coupled with mass spectrometry. Mol. Cell. Proteom.1, 947-955
DOI
|
2 |
Batmunkh, E., Ttrai, P., Szab , E., L di, C., Holczbauer, A., Pska, C., Kupcsulik, P., Kiss, A., Schaff, Z., and Kovalszky, I. (2007). Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma. Hum. Pathol. 38, 1508-1515
DOI
PUBMED
ScienceOn
|
3 |
Bix, G., and Iozzo, R.V. (2005). Matrix revolutions: 'tails' of basement-membrane components with angiostatic functions. Trends Cell Biol. 15, 52-60
DOI
PUBMED
ScienceOn
|
4 |
Cohen, I.R., Murdoch, A.D., Naso, M.F., Marchetti, D., Berd, D., and Iozzo, R.V. (1994). Abnormal expression of perlecan proteoglycan in metastatic melanomas. Cancer Res. 54, 5771-5774
PUBMED
|
5 |
Costell, M., Carmona, R., Gustafsson, E., Gonzalez-Iriarte, M., Fassler, R., and Munoz-Chapuli, R. (2002). Hyperplastic conotruncal endo-cardial cushions and transposition of great arteries in perlecan-null mice. Circ. Res. 91, 158-164
DOI
PUBMED
ScienceOn
|
6 |
Dhanabal, M., Ramchandran, R., Waterman, M.J., Lu, H., Knebelmann, B., Segal, M., and Sukhatme, V.P. (1999). Endostatin induces endothelial cell apoptosis. J. Biol. Chem. 274, 11721-11726
DOI
PUBMED
ScienceOn
|
7 |
Donahue, J.E., Berzin, T.M., Rafii, M.S., Glass, D.J., Yancopoulos, G.D., Fallon, J.R., and Stopa, E.G. (1999). Agrin in Alzheimer's disease: Altered solubility and abnormal distribution within microvasculature and brain parenchyma. Proc. Natl. Acad. Sci.USA 96, 6468-6472
DOI
PUBMED
ScienceOn
|
8 |
Ferreras, M., Felbor, U., Lenhard, T., Olsen, B.R., and Delaisse, J. (2000). Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett. 486, 247-251
DOI
PUBMED
ScienceOn
|
9 |
Gronborg, M., Kristiansen, T.Z., Iwahori, A., Chang, R., Reddy, R., Sato, N., Molina, H., Jensen, O.N., Hruban, R.H., Goggins, M.G., et al. (2006). Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol. Cell. Proteom. 5, 157-171
DOI
ScienceOn
|
10 |
Halfter, W., Dong, S., Schurer, B., and Cole, G.J. (1998). Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J. Biol. Chem. 273, 25404-25412
DOI
PUBMED
ScienceOn
|
11 |
Hilgenberg, L.G.W., Su, H., Gu, H., O'Dowd, D.K., and Smith, M.A. (2006). 3/-ATPase is a neuronal receptor for agrin. Cell 125, 359-369
DOI
PUBMED
ScienceOn
|
12 |
Iozzo, R.V. (1994). Perlecan: a gem of a proteoglycan. Matrix Biol. 14, 203-208
DOI
PUBMED
ScienceOn
|
13 |
Krishna, J., Shah, Z.A., Merchant, M., Klein, J.B., and Gozal, D. (2006). Urinary protein expression patterns in children with sleep-disordered breathing: preliminary findings. Sleep Med. 7, 221-227
DOI
PUBMED
ScienceOn
|
14 |
Laplante, P., Raymond, M.-A., Labelle, A., Abe, J.-I., Iozzo, R.V., and Hebert, M.-J. (2006). Perlecan proteolysis induces 2 1 integrin and src-family kinases dependent anti-apoptotic pathway in fibroblasts in the absence of focal adhesion kinase activation. J. Biol. Chem. 281, 30383-30392
DOI
PUBMED
ScienceOn
|
15 |
Nitkin, R.M., Smith, M.A., Magill, C., Fallon, J.R., Yao, Y.-M.M., Wallace, B.G., and McMahan, U.J. (1987). Identification of agrin, a synaptic organizing protein from Torpedo electric organ. J. Cell Biol. 105, 2471-2478
DOI
PUBMED
|
16 |
Li, Q., and Olsen, B.R. (2004). Increased angiogenic response in aortic explants of collagen XVIII/endostatin-null mice. Am. J. Pathol. 165, 415-424
DOI
PUBMED
ScienceOn
|
17 |
Marneros, A.G., and Olsen, B.R. (2005). Physiological role of collagen XVIII and endostatin. FASEB J. 19, 716-728
DOI
PUBMED
ScienceOn
|
18 |
Marneros, A.G., She, H., Zambarakji, H., Hashizume, H., Connolly, E.J., Kim, I., Gragoudas, E.S., Miller, J.W., and Olsen, B.R. (2007). Endogenous endostatin inhibits choroidal neovascularization. FASEB J. 21, 3809-3818
DOI
PUBMED
ScienceOn
|
19 |
Oh, S.P., Kamagata, Y., Muragaki, Y., Timmons, S., Ooshima, A., and Olsen, B.R. (1994a). Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins. Proc. Natl. Acad. Sci. USA 91, 4229-4233
DOI
PUBMED
ScienceOn
|
20 |
Rehn, M., Hintikka, E., and Pihlajaniemi, T. (1994). Primary structure of the a1 chain of mouse type XVIII collagen, partial structure of the corresponding gene, and comparison of the 1(XVIII) chain with its homologue, the 1 (XV) collagen chain. J. Biol. Chem. 269, 13929-13935
PUBMED
|
21 |
Rossi, M., Morita, H., Sormunen, R., Airenne, S., Kreivi, M., Wang, L., Fukai, N., Olsen, B.R., Tryggvason, K., and Soininen, R. (2003). Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. EMBO J. 22, 236-245
DOI
PUBMED
ScienceOn
|
22 |
Ttrai, P., Dudas, J., Batmunkh, E., Mth, M., Zalatnai, A., Schaff, Z., Ramadori, G., and Kovalszky, I. (2006). Agrin, a novel basement membrane component in human rat and liver, accumulates in cirrhosis and hepatocellular carcinoma. Lab. Invest. 86, 1149-1160
PUBMED
|
23 |
Sauter, B.V., Martinet, O., Zhang, W.-J., Mandeli, J., and Woo, S.L.C. (2001). Adenovirus-mediated gene transfer of endostatin vivo results in high level of transgene expression and inhibition of tumor growth and metastasis. Proc. Natl. Acad. Sci. USA 97, 4802-4807
DOI
ScienceOn
|
24 |
Scotton, P., Bleckmann, D., Stebler, M., Sciandra, F., Brancaccio, A., Meier, T., Stetefeld, J., and Ruegg, M.A. (2006). Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin. J. Biol. Chem. 281, 36835-36845
DOI
PUBMED
ScienceOn
|
25 |
Seppinen, L., Sormunen, R., Soini, Y., Elamaa, H., Heljasvaara, R., and Pihlajaniemi, T. (2008). Lack of collagen XVIII accelerates cutaneous wound healing, while overexpression of its endostatin domain leads to delayed healing. Matrix Biol. 102, 535-546
DOI
PUBMED
ScienceOn
|
26 |
Tran, P.-K., Tran-Lundmark, K., Soininen, R., Tryggvason, K., Thyberg, J., and Hedin, U. (2004). Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan. Circ. Res. 94, 550-558
DOI
PUBMED
ScienceOn
|
27 |
Wickstrm, S.A., Alitalo, K., and Keski-Oja, J. (2005). Endostatin signaling and regulation of endothelial cell-matrix interactions. Adv. Cancer Res. 94, 197-229
DOI
ScienceOn
|
28 |
Woodall, B.P., Nystrm, A., Iozzo, R.A., Eble, J.A., Niland, S., Krieg, T., Eckes, B., Pozzi, A., and Iozzo, R.V. (2008). Integrin 21 is the required receptor for endorepellin angiostatic activity. J. Biol.Chem. 283, 2335-2343
DOI
PUBMED
ScienceOn
|
29 |
Winzen, U., Cole, G.J., and Halfter, W. (2003). Agrin is a chimeric proteoglycan with the attachment sites for heparan sulfate/chondroitin sulfate located in two multiple serine-glycine clusters. J. Biol. Chem. 278, 30106-30114
DOI
PUBMED
ScienceOn
|
30 |
Witmer, A.N., van den Born, J., Vrensen, G.F.J.M., and Schlingemann, R.O. (2001). Vascular localization of heparan sulfate proteoglycans in retinas of patients with diabetes mellitus and in VEGF-induced retinopathy using domain-specific antibodies.Curr. Eye Res. 22, 190-197
DOI
PUBMED
ScienceOn
|
31 |
Zhang, Z., Ramirez, N.E., Yankeelov, T.E., Li, Z., Ford, L.E., Qi, Y., Pozzi, A., and Zutter, M.M. (2008). 21 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell-specific manner. Blood 111, 1980-1988
DOI
PUBMED
ScienceOn
|
32 |
Zorick, T.S., Mustacchi, Z., Bando, S.Y., Zatz, M., Moreira-Filho, C.A., Olsen, B., and Passos-Bueno, M.R. (2001). High serum endostatin levels in Down syndrome: Implications for improved treatment and prevention of solid tumors. Eur. J. Hum. Genet. 9, 811-814
DOI
ScienceOn
|
33 |
Zhang, J., Wang, Y., Chu, Y., Su, L., Gong, Y., Zhang, R., and Xiong, S. (2006). Agrin is involved in lymphocytes activation that is mediated by -dystroglycan. FASEB J. 20, 50-58
DOI
PUBMED
ScienceOn
|
34 |
Yurchenco, P.D., Amenta, P.S., and Patton, B.L. (2004). Basement membrane assembly, stability and activities observed through a developmental lens. Matrix Biol. 22, 521-538
DOI
PUBMED
ScienceOn
|
35 |
Aviezer, D., Iozzo, R.V., Noonan, D.M., and Yayon, A. (1997). Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA. Mol. Cell. Biol. 17, 1938-1946
DOI
PUBMED
|
36 |
Kim, Y.-M., Hwang, S., Kim, Y.-M., Pyun, B.-J., Kim, T.-Y., Lee, S.-T., Gho, Y.S., and Kwon, Y.-G. (2002). Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J. Biol. Chem. 277, 27872-27879
DOI
PUBMED
ScienceOn
|
37 |
Reiland, J., Sanderson, R.D., Waguespack, M., Barker, S.A., Long, R., Carson, D.D., and Marchetti, D. (2004). Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion. J. Biol. Chem. 279, 8047-8055
DOI
PUBMED
ScienceOn
|
38 |
Klein, G., Conzelmann, S., Beck, S., Timpl, R., and Muller, C.A. (1995). Perlecan in human bone marrow: a growth-factor presenting, but anti-adhesive, extracellular matrix component for hematopoietic cells. Matrix Biol. 14, 457-465
DOI
PUBMED
ScienceOn
|
39 |
O'Reilly, M.S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W.S., Flynn, E., Birkhead, J.R., Olsen, B.R., and Folkman, J. (1997). Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285
DOI
PUBMED
ScienceOn
|
40 |
Senger, D.R., Perruzzi, C.A., Streit, M., Koteliansky, V.E., de Fougerolles, A.R., and Detmar, M. (2002). The 11 and 21 integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am. J. Pathol. 160, 195-204
DOI
PUBMED
ScienceOn
|
41 |
Zweers, M.C., Davidson, J.M., Pozzi, A., Hallinger, R., Janz, K., Quondamatteo, F., Leutgeb, B., Krieg, T., and Eckes, B. (2007). Integrin 21 is required for regulation of murine wound angiogenesis but is dispensable for reepithelialization. J. Invest. Dermatol. 127, 467-478
DOI
ScienceOn
|
42 |
Dong, S., Cole, G.J., and Halfter, W. (2003). Expression of collagen XVIII and localization of its glycosaminoglycan attachment sites. J. Biol. Chem. 278, 1700-1707
DOI
PUBMED
ScienceOn
|
43 |
Clamp, A.R., and Jayson, G.C. (2005). The clinical potential of antiangiogenic fragments of extracellular matrix proteins. Br. J.Cancer 93, 967-972
DOI
PUBMED
ScienceOn
|
44 |
Gautam, M., Noakes, P.G., Moscoso, L., Rupp, F., Scheller, R.H., Merlie, J.P., and Sanes, J.R. (1996). Defective neuromuscular synaptogenesis in agrin-deficient mice. Cell 85, 525-535
DOI
PUBMED
ScienceOn
|
45 |
Grenache, D.G., Zhang, Z., Wells, L.E., Santoro, S.A., Davidson, J.M., and Zutter, M.M. (2006). Wound healing in the 2 1 integrin-deficient mouse: altered keratinocyte biology and dysregulated matrix metalloproteinase expression. J. Invest. Dermatol. 127, 455-466
DOI
PUBMED
ScienceOn
|
46 |
Cailhier, J.-F., Sirois, I., Raymond, M.-A., Lepage, S., Laplante, P., Brassard, N., Prat, A., Iozzo, R.V., Pshezhetsky, A.V., and Hebert, M.-J. (2008). Caspase-3 activation triggers extracellular release of cathepsin L and endorepellin proteolysis. J. Biol. Chem. 283, 27220-27229
DOI
PUBMED
ScienceOn
|
47 |
Gonzlez-Iriarte, M., Carmona, R., Perez-Pomares, J.M., Macías, D., Costell, M., and Munoz-Chapuli, R. (2003). Development of the coronary arteries in a murine model of transposition of great arteries. J. Mol. Cell. Cardio. 35, 795-802
DOI
ScienceOn
|
48 |
Zhou, Z., Wang, J., Cao, R., Morita, H., Soininen, R., Chan, K.M., Liu, B., Cao, Y., and Tryggvason, K. (2004). Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice. Cancer Res. 64, 4699-4702
DOI
ScienceOn
|
49 |
Lin, S., Maj, M., Bezakova, G., Magyar, J.P., Brenner, H.R., and Ruegg, M.A. (2008). Muscle-wide secretion of a miniaturized form of neural agrin rescues focal neuromuscular innervation in agrin mutant mice. Proc. Natl. Acad. Sci. USA 105, 11406-11411
DOI
PUBMED
ScienceOn
|
50 |
Sudhakar, A., Sugimoto, H., Yang, C., Lively, J., Zeisberg, M., and Kalluri, R. (2003). Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by v3 and 51 integrins. Proc. Natl. Acad. Sci. USA 100, 4766-4771
DOI
PUBMED
ScienceOn
|
51 |
Iozzo, R.V., and San Antonio, J.D. (2001). Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J. Clin. Invest. 108, 349-355
DOI
ScienceOn
|
52 |
Kadenhe-Chiweshe, A., Papa, J., McCrudden, K.W., Frischer, J., Bae, J.-O., Huang, J., Fisher, J., Lefkowitch, J.H., Feirt, N., Rudge, J., et al. (2008). Sustained VEGF blockade results in mi croenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation. Mol. Cancer Res. 6, 1-9
DOI
PUBMED
ScienceOn
|
53 |
Verbeek, M.M., Otte-Hller, I., van den Born, J., van den Heuvel, L.P.W.J., David, G., Wesseling, P., and de Waal, R.M. (1999). Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain. Am. J. Pathol. 155, 2115-2125
DOI
PUBMED
ScienceOn
|
54 |
Denzer, A.J., Sculthess, T., Fauser, C., Schumacher, B., Kammerer, R.A., Engel, J., and Ruegg, M.A. (1998). Electron microscopic structure of agrin and mapping of its binding site in laminin-1. EMBO J. 17, 335-343
DOI
PUBMED
ScienceOn
|
55 |
Fuki, I., Iozzo, R.V., and Williams, K.J. (2000). Perlecan heparan sulfate proteoglycan. A novel receptor that mediates a distinct pathway for ligand catabolism. J. Biol. Chem. 275, 25742-25750
DOI
PUBMED
ScienceOn
|
56 |
Iozzo, R.V. (2005). Basement membrane proteoglycans: from cellar to ceiling. Nature Rev. Mol. Cell Biol. 6, 646-656
DOI
ScienceOn
|
57 |
Iozzo, R.V., Pillarisetti, J., Sharma, B., Murdoch, A.D., Danielson, K.G., Uitto, J., and Mauviel, A. (1997). Structural and functional characterization of the human perlecan gene promoter. Transcriptional activation by transforming growth factor- via a nuclear factor 1-binding element. J. Biol. Chem. 272, 5219-5228
DOI
PUBMED
ScienceOn
|
58 |
Tsangaris, G.T., Karamessinis, P., Kolialexi, A., Garbis, S.D., Antsaklis, A., Mavrou, A., and Fountoulakis, M. (2006). Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics 6, 4410-4419
DOI
PUBMED
ScienceOn
|
59 |
Arikawa-Hirasawa, E., Watanabe, E., Takami, H., Hassell, J.R., and Yamada, Y. (1999). Perlecan is essential for cartilage and cephalic development. Nature Genet. 23, 354-358
DOI
PUBMED
ScienceOn
|
60 |
Hassell, J.R., Yamada, Y., and Arikawa-Hirasawa, E. (2003). Role of perlecan in skeletal development and diseases. Glycoconj. J. 19, 263-267
DOI
ScienceOn
|
61 |
Nyberg, P., Xie, L., and Kalluri, R. (2005). Endogenous inhibitors of angiogenesis. Cancer Res. 65, 3967-3979
DOI
PUBMED
ScienceOn
|
62 |
Vuadens, F., Benay, C., Crettaz, D., Gallot, D., Sapin, V., Schneider, P., Binevenut, W.-V., Lmery, D., Quadroni, M., Dastugue, B., et al. (2003). Identification of biologic markers of the premature rupture of fetal membranes: proteomic approach. Proteomics 3, 1521-1525
DOI
PUBMED
ScienceOn
|
63 |
Kuo, C.J., LaMontagne, K.R., Garcia-Cardena, G., Ackley, B.D., Kalman, D., Park, S., Christofferson, R., Kamihara, J., Ding,Y.-H., Lo, K.-M., et al. (2001). Oligomerization-dependent regulation of motility and morphogenesis by the collagen XVIII NC1/ endostatin domain. J. Cell Biol. 152, 1233-1246
DOI
PUBMED
|
64 |
Mongiat, M., Sweeney, S., San Antonio, J.D., Fu, J., and Iozzo, R.V. (2003). Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J. Biol. Chem. 278, 4238-4249
DOI
PUBMED
ScienceOn
|
65 |
Moulton, K.S., Olsen, B.R., Sonn, S., Fukai, N., Zurakowski, D., and Zeng, X. (2004). Loss of collagen XVIII enhances neovascularization and vascular permeability in atherosclerosis. Circulation 110, 1330-1336
DOI
PUBMED
ScienceOn
|
66 |
Warth, A., Krger, S., and Wolburg, H. (2004). Redistribution of aquaporin-4 in human glioblastoma correlates with loss of agrin immunoreactivity from brain capillary basal laminae. Acta Neuropathol. 107, 311-318
DOI
PUBMED
|
67 |
Whitelock, J.M., Graham, L.D., Melrose, J., Murdoch, A.D., Iozzo, R.V., and Underwood, P.A. (1999). Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells. Matrix Biol. 18, 163-178
DOI
PUBMED
ScienceOn
|
68 |
Burgess, R.W., Dickman, D.K., Nunez, L., Glass, D.J., and Sanes, J.R. (2002). Mapping sites responsible for interactions of agrin with neurons. J. Neurochem. 83, 271-284
DOI
PUBMED
ScienceOn
|
69 |
Gesemann, M., Brancaccio, A., Schumacher, B., and Ruegg, M.A. (1998). Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue. J. Biol. Chem. 273, 600-605
DOI
PUBMED
ScienceOn
|
70 |
Lin, W., Burgess, R.W., Dominguez, B., Pfaff, S.L., Sanes, J.R., and Lee, K.-F. (2001). Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse. Nature 410, 1057-1064
DOI
PUBMED
ScienceOn
|
71 |
Elamaa, H., Snellman, A., Rehn, M., Autio-Harmainen, H., and Pihlajaniemi, T. (2003). Characterization of the human type XVIII collagen gene and proteolytic processing and tissue location of the variant containing a frizzled motif. Matrix Biol. 22, 427-442
DOI
PUBMED
ScienceOn
|
72 |
Sasaki, T., Fukai, N., Mann, K., Gohring, W., Olsen, B.R., and Timpl, R. (1998). Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J. 17, 4249-4256
DOI
PUBMED
ScienceOn
|
73 |
Whitelock, J.M., Melrose, J., and Iozzo, R.V. (2008). Diverse cell signaling events modulated by perlecan. Biochemistry 47, 11174-11183
DOI
PUBMED
ScienceOn
|
74 |
Matsumoto-Miyai, K., Sokolowska, E., Zurlinden, A., Gee, C.E., Luscher, D., Hettwer, S., Wolfel, J., Ladner, A.P., Ster, J., Gerber, U., et al. (2009). Coincident pre- and postsynaptic activation induces dendritic filopodia via neurotrypsin-dependent agrin cleavage. Cell 136, 1161-1171
DOI
PUBMED
ScienceOn
|
75 |
Menzel, O., Bekkeheien, R.C., Reymond, A., Fukai, N., Boye, E., Kosztolanyi, G., Aftimos, S., Deutsch, S., Scott, H.S., Olsen, B.R., et al. (2004). Knobloch syndrome: novel mutations in COL18A1, evidence for genetic heterogeneity, and a functionally impaired polymorphism in endostatin. Hum. Mutat. 23, 77-84
DOI
PUBMED
ScienceOn
|
76 |
Aviezer, D., Hecht, D., Safran, M., Eisinger, M., David, G., and Yayon, A. (1994). Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis,and angiogenesis. Cell 79, 1005-1013
DOI
PUBMED
ScienceOn
|
77 |
Bix, G., Castello, R., Burrows, M., Zoeller, J.J., Weech, M., Iozzo, R.A., Cardi, C., Thakur, M.T., Barker, C.A., Camphausen, K.C., et al. (2006). Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism. J. Natl. Cancer Inst. 98, 1634-1646
DOI
PUBMED
ScienceOn
|
78 |
Marneros, A.G., Keene, D.R., Hansen, U., Fukai, N., Moulton, K., Goletz, P.L., Moiseyev, G., Pawlyk, B.S., Halfter, W., Dong, S., et al. (2004). Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function. EMBO J. 23, 89-99
DOI
PUBMED
ScienceOn
|
79 |
Robinson, C.J., Mulloy, B., Gallagher, J.T., and Stringer, S.E. (2006). VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase. J. Biol. Chem. 281, 1731-1740
DOI
PUBMED
ScienceOn
|
80 |
Utriainen, A., Sormunen, R., Kettunen, M., Carvalhaes, L.S., Sajanti, E., Eklund, L., Kauppinen, R., Kitten, G.T., and Pihlajaniemi, T. (2004). Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deficient mouse line. Human Mol. Gen. 13, 2089-2099
DOI
ScienceOn
|
81 |
Farach-Carson, M.C., and Carson, D.D. (2007). Perlecan - a multifunctional extracellular proteoglycan scaffold. Glycobiology 17, 897-905
DOI
PUBMED
ScienceOn
|
82 |
Ghiselli, G., Eichstetter, I., and Iozzo, R.V. (2001). A role for the perlecan protein core in the activation of the keratinocyte growth factor receptor. Biochem. J. 359, 153-163
DOI
PUBMED
ScienceOn
|
83 |
Nugent, M.A., and Iozzo, R.V. (2000). Fibroblast growth factor-2. Int. J. Biochem. Cell Biol. 32, 115-120
DOI
PUBMED
ScienceOn
|
84 |
Oh, S.P., Warman, M.L., Seldin, M.F., Cheng, S.-D., Knoll, J.H.M., Timmons, S., and Olsen, B.R. (1994b). Cloning of cDNA and genomic DNA encoding human type XVIII collagen and localization of the 1(XVIII) collagen gene to mouse chromosome 10 and human chromosome 21. Genomics 19, 494-499
DOI
PUBMED
ScienceOn
|
85 |
Fukai, N., Eklund, L., Marneros, A.G., Oh, S.P., Keene, D.R., Tamarkin, L., Niemela, M., Ilves, M., Li, E., Pihlajaniemi, T., et al. (2002). Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J. 21, 1535-1544
DOI
PUBMED
ScienceOn
|
86 |
Iozzo, R.V., Cohen, I.R., Grassel, S., and Murdoch, A.D. (1994). The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem. J. 302, 625-639
DOI
PUBMED
|
87 |
Mathiak, M., Yenisey, C., Grant, D.S., Sharma, B., and Iozzo, R.V. (1997). A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells. Cancer Res. 57, 2130-2136
PUBMED
|
88 |
Reif, R., Sales, S., Hettwer, S., Dreier, B., Gisler, C., Wolfel, J., Luscher, D., Zurlinden, A., Stephan, A., Ahmed, S., et al. (2007). Specific cleavage of agrin by neurotrypsin, a synaptic protease linked to mental retardation. FASEB J. 21, 3468-3478
DOI
PUBMED
ScienceOn
|
89 |
Costell, M., Gustafsson, E., Aszodi, A., Morgelin, M., Bloch, W., Hunziker, E., Addicks, K., Timpl, R., and Fassler, R. (1999). Perlecan maintains the integrity of cartilage and some basement membranes. J. Cell Biol. 147, 1109-1122
DOI
PUBMED
|
90 |
Bix, G., and Iozzo, R.V. (2008). Novel interactions of perlecan: Unraveling perlecan's role in angiogenesis. Microsc. Res. 71, 339-348
DOI
ScienceOn
|
91 |
Karumanchi, S.A., Jha, V., Ramchandran, R., Karihaloo, A., Tsiokas, L., Chan, B., Dhanabai, M., Hanai, J.-C., Venkataraman, G., Shriver, Z., et al. (2001). Cell surface glypicans are low-affinity endostatin receptors. Mol. Cell 7, 811-822
DOI
PUBMED
ScienceOn
|
92 |
Sharma, B., Handler, M., Eichstetter, I., Whitelock, J., Nugent, M.A., and Iozzo, R.V. (1998). Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. J. Clin. Invest. 102, 1599-1608
DOI
PUBMED
ScienceOn
|
93 |
Savor, C., Zhang, C., Muir, C., Liu, R., Wyrwa, J., Shu, J., Zhau, H.E., Chung, L.W., Carson, D.D., and Farach-Carson, M.C. (2005). Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo. Clin. Exp. Metastasis 22, 377-390
DOI
|
94 |
Zatterstrom, U.K., Felbor, U., Fukai, N., and Olsen, B.R. (2000). Collagen XVIII/endostatin structure and functional role in angiogenesis. Cell Struct. Funct. 25, 97-101
DOI
PUBMED
ScienceOn
|
95 |
Iozzo, R.V., and Murdoch, A.D. (1996). Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J. 10, 598-614
DOI
PUBMED
|
96 |
Sund, M., Zeisberg, M., and Kalluri, R. (2005). Endogenous stimulators and inhibitors of angiogenesis in gastrointestinal cancers: basic science to clinical application. Gastroenterology 129, 2076-2091
DOI
PUBMED
ScienceOn
|
97 |
Gonzalez, E.M., Reed, C.C., Bix, G., Fu, J., Zhang, Y., Gopalakrishnan, B., Greenspan, D.S., and Iozzo, R.V. (2005). BMP-1/Tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan. J. Biol. Chem. 280, 7080-7087
DOI
PUBMED
ScienceOn
|
98 |
Nugent, M.A., Nugent, H.M., Iozzo, R.V., Sanchack, K., and Edelman, E.R. (2000). Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia. Proc. Natl. Acad. Sci. USA 97, 6722-6727
DOI
PUBMED
ScienceOn
|
99 |
Suzuki, O.T., Sertie, A.L., Der, K.V., Kok, F., Carpenter, M., Murray, J., Czeizel, A.E., Kliemann, S.E., Rosemberg, S., Monteiro, M., et al. (2002). Molecular analysis of collagen XVIII reveals novel mutations, presence of a third isoform, and possible genetic heterogeneity in Knobloch syndrome. Am. J. Hum. Genet. 71, 1320-1329
DOI
PUBMED
ScienceOn
|
100 |
Ylikrpp, R., Eklund, L., Sormunen, R., Kontiola, A.I., Utriainen, A., Mtt, M., Fukai, N., and Olsen, B.R. (2003). Lack of type XVIII collagen results in anterior ocular defects. FASEB J. 17, 2257-2259
DOI
PUBMED
|
101 |
Mongiat, M., Otto, J., Oldershaw, R., Ferrer, F., Sato, J.D., and Iozzo, R.V. (2001). Fibroblast growth factor-binding protein is a novel partner for perlecan protein core. J. Biol. Chem. 276, 10263-10271
DOI
PUBMED
ScienceOn
|
102 |
Kim, N., Stiegler, A.L., Cameron, T.O., Hallock, P.T., Gomez, A.M.,Huang, J.H., Hubbard, S.R., Dustin, M.L., and Burden, S.J. (2008). Lrp4 is a receptor for agrin and forms a complex with MuSK. Cell 135, 334-342
DOI
ScienceOn
|
103 |
Abdollahi, A., Hahnfeldt, P., Maercker, C., Grne, H.-J., Debus, J., Ansorge, W., Folkman, J., Hlatky, L., and Huber, P.E. (2004). Endostatin's antioangiogenic signaling network. Mol. Cell 13, 649-663
DOI
ScienceOn
|
104 |
Bezakova, G., and Ruegg, M.A. (2003). New insights into the roles of agrin. Nature Rev. Mol. Cell Biol. 4, 295-308
DOI
ScienceOn
|
105 |
Sweeney, S.M., DiLullo, G., Slater, S.J., Martinez, J., Iozzo, R.V., Lauer-Fields, J.L., Fields, G.B., and San Antonio, J.D. (2003). Angiogenesis in collagen I requires 21 ligation of a GFPGER sequence and possible p38 MAPK activation and focal adhesion disassembly. J. Biol. Chem. 278, 30516-30524
DOI
PUBMED
ScienceOn
|
106 |
Whitelock, J.M., Murdoch, A.D., Iozzo, R.V., and Underwood, P.A. (1996). The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin and heparanases. J. Biol. Chem. 271, 10079-10086
DOI
PUBMED
|
107 |
Zoeller, J.J., McQuillan, A., Whitelock, J., Ho, S.-Y., and Iozzo, R.V. (2008). A central function for perlecan in skeletal muscle and cardiovascular development. J. Cell Biol. 181, 381-394
DOI
ScienceOn
|
108 |
Hurskainen, M., Eklund, L., Hagg, P.O., Fruttiger, M., Sormunen, R., IIves, M., and Pihlajaniemi, T. (2005). Abnormal maturation of the retinal vasculature in type XVIII collagen/endostatin deficient mice and changes in retinal glial cells due to lack of collagen types XV and XVIII. FASEB J. 19, 1564-1666
DOI
PUBMED
|
109 |
Groffen, A.J.A., Buskens, C.A.F., van Kuppevelt, T.H., Veerkamp, J.H., Monnens, L.A.H., and van den Heuvel, L.P.W.J. (1998). Primary structure and high expression of human agrin in basement membranes of adult lung and kidney. Eur. J. Biochem. 254, 123-128
DOI
PUBMED
ScienceOn
|
110 |
Handler, M., Yurchenco, P.D., and Iozzo, R.V. (1997). Developmental expression of perlecan during murine embryogenesis. Dev. Dyn. 210, 130-145
DOI
PUBMED
ScienceOn
|
111 |
West, L., Govindraj, P., Koob, T.J., and Hassell, J.R. (2006). Changes in perlecan during chondrocyte differentiation in the fetal bovine rib growth plate. J. Orthop. Res. 24, 1317-1326
DOI
PUBMED
ScienceOn
|
112 |
Baerwald-De La Torre, K., Winzen, U., Halfter, W., and Bixby, J.L. (2004). Glycosaminoglycan-dependent and -independent inhibition of neurite outgrowth by agrin. J. Neurochem. 90, 50-61
DOI
PUBMED
ScienceOn
|
113 |
Rehn, M., Veikkola, T., Kukk-Valdre, E., Nakamura, H., Ilmonen, M., Lombardo, C.R., Pihlajaniemi, T., Alitalo, K., and Vuori, K. (2001). Interaction of endostatin with integrins implicated in angiogenesis. Proc. Natl. Acad. Sci. USA 98, 1024-1029
DOI
PUBMED
ScienceOn
|
114 |
Thadikkaran, L., Crettaz, D., Siegenthaler, M.A., Gallot, D., Sapin, V., Iozzo, R.V., Queloz, P.A., Schneider, P., and Tissot, J.D. (2005). The role of proteomics in the assessment of premature rupture of fetal membranes. Clin. Chim. Acta 360, 27-36
DOI
PUBMED
ScienceOn
|
115 |
Whitelock, J.M., and Iozzo, R.V. (2005). Heparan sulfate: a complex polymer charged with biological activity. Chem. Rev. 105, 2745-2764
DOI
PUBMED
ScienceOn
|
116 |
Gianazza, E., Wait, R., Begum,S., Eberini, I., Campagnoli, M., Labo, S., and Galliano, M. (2007). Mapping the 5-50-kDa fraction of human amniotic fluid proteins by 2-DE and ESI-MS. Proteomics Clin. Appl. 1, 167-175
DOI
ScienceOn
|
117 |
Iozzo, R.V. (1998). Matrix proteoglycans: from molecular design to cellular function. Annu. Rev. Biochem. 67, 609-652
DOI
PUBMED
ScienceOn
|
118 |
O'Riordan, E., Orlova, T.N., Mendelev, N., Patschan, D., Kemp, R., Chander, P.N., Hu, R., Hao, G., Gross, S.S., Iozzo, R.V., et al. (2008). Urinary proteomic analysis of chronic renal allograft nephropathy. Proteomics Clin. Appl. 2, 1025-1035
DOI
ScienceOn
|
119 |
Saarela, J., Ylikarppa, R., Rehn, M., Purmonen, S., and Pihlajaniemi, T. (1998). Complete primary structure of two variant forms of human type XVIII collagen and tissue-specific differences in the expression of the corresponding transcripts. Matrix Biol. 16, 319-328
DOI
PUBMED
ScienceOn
|
120 |
Shichiri, M., and Hirata, Y. (2001). Antiangiogenesis signals by endostatin. FASEB J. 15, 1044-1053
DOI
PUBMED
ScienceOn
|
121 |
Raymond, M.-A., Desormeaux, A., Laplante, P., Vigneault, N., Filep, J.G., Landry, K., Pshezhetsky, A.V., and Hebert, M.-J. (2004). Apoptosis of endothelial cells triggers a caspase-dependent anti-apoptotic paracrine loop active on vascular smooth muscle cells. FASEB J. 18, 705-707
DOI
PUBMED
ScienceOn
|
122 |
Adatia, R., Albini, A., Carlone, S., Giunciuglio, D., Benelli, R., Santi,L., and Noonan, D.M. (1998). Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA. Ann. Oncol. 8, 1257-1261
|
123 |
Bix, G., Fu, J., Gonzalez, E., Macro, L., Barker, A., Campbell, S., Zutter, M.M., Santoro, S.A., Kim, J.K., Hk, M., et al. (2004). Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through the 21 integrin. J. Cell Biol. 166, 97-109
DOI
PUBMED
ScienceOn
|
124 |
Laplante, P., Raymond, M.A., Gagnon, G., Vigneault, N., Sasseville, A.M., Langelier, Y., Bernard, M., Raymond, Y., and Hebrt, M.-J. (2005). Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis. J. Immunol. 174, 5740-5749
DOI
PUBMED
|
125 |
Bix, G., Iozzo, R.A., Woodall, B., Burrows, M., McQuillan, A., Campbell, S., Fields, G.B., and Iozzo, R.V. (2007). Endorepellin, the C-terminal angiostatic module of perlecan, enhances collagen-platelet responses via the 21 integrin receptor. Blood 109,3745-3748
DOI
PUBMED
ScienceOn
|
126 |
Chang, J.W., Kang, U.-B., Kim, D.H., Yi, J.K., Lee, J.W., Noh, D.-Y., Lee, C., and Yu, M.-H. (2008). Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer. Proteomics Clin. Appl. 2, 23-32
DOI
ScienceOn
|
127 |
Mongiat, M., Taylor, K., Otto, J., Aho, S., Uitto, J., Whitelock, J., and Iozzo, R.V. (2000). The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. J. Biol. Chem. 275, 7095-7100
DOI
PUBMED
ScienceOn
|
128 |
Oda, O., Shinzato, T., Ohbayashi, K., Takai, I., Kunimatsu, M., Maeda, K., and Yamanaka, N. (1996). Purification and characterization of perlecan fragment in urine of end-stage renal failure patients. Clin. Chim. Acta 255, 119-132
DOI
PUBMED
ScienceOn
|
129 |
Zoeller, J.J., and Iozzo, R.V. (2008). Proteomic profiling of endorepellin angiostatic activity on human endothelial cells. Proteome Sci. 6, 7
DOI
ScienceOn
|